logo-large
  • Browse Categories

Publications by authors named "Ivan Tijanic"

Claim this Profile
I
Impact of quality of response on survival outcomes among multiple myeloma patients treated with novel agents - a retrospective analysis.
Irena Ćojbašić, Miodrag Vučić, Ivan Tijanić, Žarko Ćojbašić

Sao Paulo Med J· March 2022


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II Study to Assess the Safety and Efficacy of the Dual mTORC1/2 and PI3K Inhibitor Bimiralisib (PQR309) in Relapsed, Refractory Lymphoma.
Graham P Collins, Toby A Eyre, Debora Schmitz-Rohmer, William Townsend, Rakesh Popat, Ivan Tijanic

Hemasphere· November 2021


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analyses of Treatment Outcome According to Age in Patients With Chronic Myeloid Leukemia Receiving Front-line Imatinib Therapy.
Irena Ćojbašić, Lana Mačukanović-Golubović, Miodrag Vučić, Ivan Tijanić

Clin Lymphoma Myeloma Leuk· October 2017


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
© PubHawk
  • About PubHawk
  • Privacy Policy
  • Sitemap
Socials: